DUBLIN--(BUSINESS WIRE)--The "Global Sensory Organ Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Sensory Organ Partnering 2012 to 2018 provides the full collection of Sensory Organ disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Sensory Organ disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sensory Organ deals.
The report presents financial deal terms values for Sensory Organ deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
In addition, a comprehensive appendix is provided with each report of all Sensory Organ partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Sensory Organ dealmaking
Chapter 3 - Financial deal terms for Sensory Organ partnering
Chapter 4 - Leading Sensory Organ deals and dealmakers
Chapter 5 - Sensory Organ contract document directory
Chapter 6 - Sensory Organ dealmaking by therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/ltqbkp/global_sensory?w=4